Kymera Therapeutics, Inc. - COM (KYMR)

Historical Portfolio Holders from Q3 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
66.5 M
Holdings value Q1 2024
$2.67 B
Value change Q1 2024
+$295 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
154
Number of buys Q1 2024
93
Number of sells Q1 2024
-57
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.003%
CUSIP
501575104
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 66.5 M $2.67 B +$295 M $40.20 154
2023 Q4 60 M $1.53 B +$89.3 M $25.46 131
2023 Q3 57.2 M $795 M -$17.6 M $13.90 118
2023 Q2 58 M $1.33 B +$24.1 M $22.99 121
2023 Q1 56.8 M $1.68 B +$23.2 M $29.63 122
2022 Q4 56.1 M $1.4 B +$97.8 M $24.96 116
2022 Q3 50.9 M $1.11 B +$28 M $21.77 112
2022 Q2 49.2 M $968 M +$11.5 M $19.69 97
2022 Q1 45.3 M $1.92 B +$61.7 M $42.32 124
2021 Q4 43.1 M $2.74 B +$117 M $63.49 122
2021 Q3 34.2 M $2.01 B +$486 M $58.74 112
2021 Q2 26.5 M $1.29 B +$190 M $48.50 109
2021 Q1 22.8 M $887 M +$90.2 M $38.86 94
2020 Q4 20 M $1.23 B +$52.3 M $62.00 72
2020 Q3 16.4 M $527 M +$527 M $32.31 50